Related Experiment Video
Updated: Feb 14, 2026

Preparation, Purification, and Use of Fatty Acid-containing Liposomes
Published on: February 9, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84
Lyne Gagnon1, Martin Leduc1, Jean-Francois Thibodeau2
1Prometic BioSciences Inc., Laval, Québec, Canada.
Abstract:
Numerous clinical conditions can lead to organ fibrosis and functional failure. There is a great need for therapies that could effectively target pathophysiological pathways involved in fibrosis. GPR40 and GPR84 are G protein-coupled receptors with free fatty acid ligands and are associated with metabolic and inflammatory disorders. Although GPR40 and GPR84 are involved in diverse physiological processes, no evidence has demonstrated the relevance of GPR40 and GPR84 in fibrosis pathways. Using PBI-4050 (3-pentylbenzeneacetic acid sodium salt), a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively, we uncovered an antifibrotic pathway involving these receptors. In experiments using Gpr40- and Gpr84-knockout mice in models of kidney fibrosis (unilateral ureteral obstruction, long-term post-acute ischemic injury, and adenine-induced chronic kidney disease), we found that GPR40 is protective and GPR84 is deleterious in these diseases. Moreover, through binding to GPR40 and GPR84, PBI-4050 significantly attenuated fibrosis in many injury contexts, as evidenced by the antifibrotic activity observed in kidney, liver, heart, lung, pancreas, and skin fibrosis models. Therefore, GPR40 and GPR84 may represent promising molecular targets in fibrosis pathways. We conclude that PBI-4050 is a first-in-class compound that may be effective for managing inflammatory and fibrosis-related diseases.
Insights
GPR40 and GPR84 receptors are involved in organ fibrosis. The drug PBI-4050 targets these receptors, showing significant antifibrotic effects across multiple organs, suggesting potential for treating fibrosis-related diseases.
Area of Science:
- Molecular biology
- Pharmacology
- Pathophysiology
Background:
- Organ fibrosis is a significant clinical challenge requiring novel therapeutic strategies.
- G protein-coupled receptors GPR40 and GPR84, linked to metabolic and inflammatory conditions, have not been previously associated with fibrosis.
- Understanding the role of GPR40 and GPR84 in fibrotic diseases is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of GPR40 and GPR84 in organ fibrosis.
- To evaluate the antifibrotic potential of PBI-4050, a compound targeting GPR40 and GPR84.
Main Methods:
- Utilized Gpr40- and Gpr84-knockout mouse models to study kidney fibrosis.
- Employed various kidney injury models: unilateral ureteral obstruction, chronic ischemic injury, and adenine-induced chronic kidney disease.
- Assessed the antifibrotic effects of PBI-4050 in multiple organ fibrosis models (kidney, liver, heart, lung, pancreas, skin).
Main Results:
- GPR40 demonstrated a protective role, while GPR84 exhibited a deleterious effect in kidney fibrosis models.
- PBI-4050 significantly attenuated fibrosis across kidney, liver, heart, lung, pancreas, and skin fibrosis models.
- The drug's efficacy was linked to its interaction with both GPR40 and GPR84.
Conclusions:
- GPR40 and GPR84 are identified as key players in fibrosis pathways, with opposing roles.
- PBI-4050 exhibits broad-spectrum antifibrotic activity, highlighting its therapeutic potential.
- GPR40 and GPR84 represent promising molecular targets for managing inflammatory and fibrosis-related diseases.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Insulin: The Receptor and Signaling Pathways
Amino Acid Biosynthetic Pathways
GTPases and their Regulation
Large G-proteins,...
Respiratory Regulation of Acid-Base Balance
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...

